Membrane Topology Mapping of Vitamin K Epoxide Reductase by in Vitro Translation/Cotranslocation*
暂无分享,去创建一个
Gunnar von Heijne | G. von Heijne | C. Nicchitta | D. Stafford | Jian-Ke Tie | Christopher Nicchitta | Darrel W Stafford | J. Tie
[1] H. Thijssen,et al. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents. , 1994, The Biochemical journal.
[2] C. Nicchitta,et al. A topological study of the human γ-glutamyl carboxylase , 2000 .
[3] J. J. Lee,et al. Metabolism of vitamin K and vitamin K 2,3-epoxide via interaction with a common disulfide. , 1984, Biochemistry.
[4] R. Bell,et al. Vitamin K activity of phylloquinone oxide. , 1970, Archives of biochemistry and biophysics.
[5] G von Heijne,et al. Consensus predictions of membrane protein topology , 2000, FEBS letters.
[6] Gunnar von Heijne,et al. Topology Models for 37 Saccharomyces cerevisiaeMembrane Proteins Based on C-terminal Reporter Fusions and Predictions* , 2003, The Journal of Biological Chemistry.
[7] D. Sane,et al. Vitamin K 2,3-epoxide reductase and the vitamin K-dependent γ-carboxylation system , 2002 .
[8] S. Hutson,et al. Assembly of the Warfarin-sensitive Vitamin K 2,3-Epoxide Reductase Enzyme Complex in the Endoplasmic Reticulum Membrane* , 1997, The Journal of Biological Chemistry.
[9] A. Holmgren,et al. Stimulation of the dithiol-dependent reductases in the vitamin K cycle by the thioredoxin system. Strong synergistic effects with protein disulphide-isomerase. , 1992, The Biochemical journal.
[10] R. Wallin,et al. Rat and human liver vitamin K epoxide reductase: inhibition by thiol blockers and vitamin K1. , 1987, The International journal of biochemistry.
[11] V. Goder,et al. Topogenesis of membrane proteins: determinants and dynamics , 2001, FEBS letters.
[12] T. Stanley,et al. Expression and Characterization of the Naturally Occurring Mutation L394R in Human γ-Glutamyl Carboxylase* , 2000, The Journal of Biological Chemistry.
[13] D. Smalley,et al. Vitamin K1 2,3-epoxide and quinone reduction: mechanism and inhibition. , 1990, Free radical research communications.
[14] A. Krogh,et al. Reliability measures for membrane protein topology prediction algorithms. , 2003, Journal of molecular biology.
[15] J. Suttie,et al. Studies of the vitamin K-dependent carboxylase and vitamin K epoxide reductase in rat liver. , 1986, Haemostasis.
[16] P. Preusch. Is thioredoxin the physiological vitamin K epoxide reducing agent? , 1992, FEBS letters.
[17] E. Israels,et al. Novel vitamin K-dependent pathways regulating cell survival , 2001, Apoptosis.
[18] G von Heijne,et al. Determination of the distance between the oligosaccharyltransferase active site and the endoplasmic reticulum membrane. , 1993, The Journal of biological chemistry.
[19] D. Stafford,et al. The Vitamin K-dependent Carboxylase , 2002, Thrombosis and Haemostasis.
[20] Rolf Apweiler,et al. Evaluation of methods for the prediction of membrane spanning regions , 2001, Bioinform..
[21] C. Esmon,et al. The interaction of a Ca2+-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca2+ binding to both antigen and antibody. , 1988, The Journal of biological chemistry.
[22] Andreas Fregin,et al. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2 , 2004, Nature.
[23] Terri K. Attwood,et al. BPROMPT: a consensus server for membrane protein prediction , 2003, Nucleic Acids Res..
[24] D. Cowell,et al. Characterization and purification of the vitamin K1 2,3 epoxide reductase system from rat liver , 2001 .
[25] B. Furie,et al. Vitamin K-Dependent Biosynthesis of γ-Carboxyglutamic Acid , 1999 .
[26] T. Guenthner,et al. Purification of warfarin-sensitive vitamin K epoxide reductase. , 1997, Methods in enzymology.
[27] A. Khvorova,et al. Identification of the gene for vitamin K epoxide reductase , 2004, Nature.
[28] G. Blobel,et al. Preparation of microsomal membranes for cotranslational protein translocation. , 1983, Methods in enzymology.
[29] J. J. Lee,et al. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction. , 1985, Biochemistry.
[30] K. Becker,et al. The thioredoxin system—From science to clinic , 2004, Medicinal research reviews.
[31] C. Schneider,et al. The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade , 1993, Molecular and cellular biology.
[32] R. Silverman,et al. Reduced thioredoxin: a possible physiological cofactor for vitamin K epoxide reductase. Further support for an active site disulfide. , 1988, Biochemical and biophysical research communications.
[33] P. Price. Role of vitamin-K-dependent proteins in bone metabolism. , 1988, Annual review of nutrition.
[34] Ylva Gavel,et al. Sequence differences between glycosylated and non-glycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering , 1990, Protein engineering.
[35] C. Ponting,et al. Vitamin K epoxide reductase: homology, active site and catalytic mechanism. , 2004, Trends in biochemical sciences.
[36] D. Sane,et al. Engineering of a Recombinant Vitamin K-dependent γ-Carboxylation System with Enhanced γ-Carboxyglutamic Acid Forming Capacity , 2005, Journal of Biological Chemistry.
[37] A. Sweatt,et al. A molecular mechanism for genetic warfarin resistance in the rat , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[38] G. von Heijne,et al. Proline-induced disruption of a transmembrane alpha-helix in its natural environment. , 1998, Journal of molecular biology.
[39] R. Silverman,et al. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone. , 1985, Proceedings of the National Academy of Sciences of the United States of America.